✦ LIBER ✦

Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer

✍ Scribed by L. Denis; G. P. Murphy

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 773 KB
Volume: 72
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19931215)72:12+<3888::aid-cncr2820721726>3.0.co;2-b

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II trial of green tea in the tre

A Phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma

✍ Aminah Jatoi; Neil Ellison; Patrick A. Burch; Jeff A. Sloan; Shaker R. Dakhil; P 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Background: Recent laboratory and epidemiologic studies have suggested that green tea has antitumor effects in patients with prostate carcinoma. this phase ii trial explored green tea's antineoplastic effects in patients with androgen independent prostate carcinoma. ## Methods: This study, whi

Treatment of newly diagnosed metastatic

Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone

✍ Gerald P. Murphy; Sunmolu Beckley; Mark F. Brady; T. Ming Chu; Jean B. Dekernion 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB

by the National Prostatic Cancer Project randomized newly diagnosed metastatic prostate cancer patients to DES 1 mg orally three times daily or orchiectomy; or DES, 1 mg, three times daily, plus cyclophosphamide at 1 mg/m2 iv every three weeks, or cyclophosphamide 1 g/m2 iv every three weeks plus es

Phase II study of capecitabine combined

Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanes

✍ Alan Rodney; Pauline Dieringer; Paul Mathew; Eric Jonasch; Nizar Tannir; Lance C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

## Abstract ## BACKGROUND The primary objective of the current study was to evaluate the effectiveness of capecitabine and gemcitabine in the treatment of patients with androgen‐independent prostate cancer (AIPCa) who experienced disease progression after taxane therapy. The secondary objective wa

Diethylstilbestrol and docetaxel : A pha

Diethylstilbestrol and docetaxel : A phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer

✍ R. Bruce Montgomery; Peter S. Nelson; Daniel Lin; Christopher W. Ryan; Mark Garz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract ## BACKGROUND. The addition of diethylstilbestrol to docetaxel modified tubulin composition and improved the response of prostate cancer to chemotherapy in preclinical models. An attempt was made to recapitulate the observations in a clinical trial. ## METHODS. Twenty‐nine patients w

Phase 2 trial of a novel capecitabine do

Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer

✍ Devika Gajria; Kim Feigin; Lee K. Tan; Sujata Patil; Stephanie Geneus; Maria The 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

A phase III randomized trial of dacarbaz

A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma

✍ Sanjiv S. Agarwala; William Ferri; William Gooding; John M. Kirkwood 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 3 views

## BACKGROUND. Metastatic melanoma is a disease associated with a poor prognosis, and dacarbazine is still the reference agent. The authors conducted a randomized trial to test the benefit of adding tamoxifen to dacarbazine and carboplatin chemotherapy for previously untreated patients with metast